caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1306055348

Hyo HanMD

PRACTICEMOFFITT CANCER CENTER & RESEARCH INSTITUTESee all providers at this practice →
Hematology-OncologyTampa, FLI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 100271
Hospital
REFERRAL NETWORK

Where Hyo Han's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 7 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
KETTNER, DAWN29143
Claudia Berman
Diagnostic Radiology · Tampa, FL
2289
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.1372,316
Claudia Berman
Diagnostic Radiology · Tampa, FL
2697
Jaime Montilla-Soler
Diagnostic Radiology · Orlando, FL
2579
KETTNER, DAWN20116
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Tampa, FL
2071
Alec Chau
Diagnostic Radiology · Tampa, FL
1220
Kenneth Gage
Diagnostic Radiology · Jacksonville, FL
1134
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
132
Unique beneficiaries
—
Total services
204
Distinct HCPCS
4
Medicare payment
$17K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 737 Hematology-Oncology providers in FL — bottom quintile (cohort median 1,932).
PRESCRIBING · PART D · 2024
Total Rx claims
254
Beneficiaries
—
Total drug cost
$1.4M
Distinct drugs
8
Brand share
31.1%
Top prescribed drugs
Anastrozole73 claims
Letrozole55 claims
Palbociclib34 claims
Exemestane24 claims
Capivasertib23 claims
QUALITY · MIPS · 2024
Final MIPS score
88.0
Quality
74.0
Cost
71.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.55%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$6K
Payment records
10
By payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$3K
Honoraria$1K
Consulting Fee$1K
Food and Beverage$690